Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer ; day:5 ; month:10 ; year:2024 ; pages:1-13
Gastric cancer ; (5.10.2024), 1-13
- Creator
-
Iden, Cecilie Riis
Mustafa, Salah Mohammad
Øgaard, Nadia
Henriksen, Tenna
Jensen, Sarah Østrup
Ahlborn, Lise Barlebo
Egebjerg, Kristian
Baeksgaard, Lene
Garbyal, Rajendra Singh
Nedergaard, Mette Kjølhede
Achiam, Michael Patrick
Andersen, Claus Lindbjerg
Mau-Sørensen, Morten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10120-024-01556-9
- URN
-
urn:nbn:de:101:1-2412232119529.743360932684
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iden, Cecilie Riis
- Mustafa, Salah Mohammad
- Øgaard, Nadia
- Henriksen, Tenna
- Jensen, Sarah Østrup
- Ahlborn, Lise Barlebo
- Egebjerg, Kristian
- Baeksgaard, Lene
- Garbyal, Rajendra Singh
- Nedergaard, Mette Kjølhede
- Achiam, Michael Patrick
- Andersen, Claus Lindbjerg
- Mau-Sørensen, Morten
- SpringerLink (Online service)
Other Objects (12)
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Role of tight junction proteins in gastroesophageal reflux disease
Two decades of gastric and gastroesophageal junction cancer surgery
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Preoperative predictors for early recurrence of resectable pancreatic cancer
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Correction: Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Role of tight junction proteins in gastroesophageal reflux disease
Two decades of gastric and gastroesophageal junction cancer surgery
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Preoperative predictors for early recurrence of resectable pancreatic cancer
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Correction: Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer
Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome
Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Role of tight junction proteins in gastroesophageal reflux disease
Two decades of gastric and gastroesophageal junction cancer surgery
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours
Preoperative predictors for early recurrence of resectable pancreatic cancer
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Correction: Endoscopic removal of an extraluminal gastrointestinal stromal tumor recurrence located on the surgical stapler line at gastroesophageal junction
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer